title: MRS is the test of choice for detecting and monitoring disorders of creatine metabolism.
authors.affiliation: Department of Radiology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA.
authors.forename: Andrew V
authors.initials: AV
authors.lastname: Barger
authors.forename: Norbert G
authors.initials: NG
authors.lastname: Campeau
authors.forename: John D
authors.initials: JD
authors.lastname: Port
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Renaud
mesh_terms: D001921:Brain / Q000473:pathology; D001923:Brain Chemistry; D003401:Creatine / Q000172:deficiency* / Q000627:therapeutic use; D002658:Developmental Disabilities / Q000175:diagnosis / Q000209:etiology; D005998:Glycine / Q000031:analogs & derivatives / Q000032:analysis; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008659:Metabolic Diseases / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D011522:Protons; D016896:Treatment Outcome
chemical_list: D011522:Protons; C004946:glycocyamine; D003401:Creatine; D005998:Glycine